Skip to main content
MEDIBANK PRIVATE LIMITED logo

MEDIBANK PRIVATE LIMITED — Investor Relations & Filings

Ticker · MPL ISIN · AU000000MPL3 LEI · BDYVSUPTML83OLINBJ17 ASX Financial and insurance activities
Open in API
Filings indexed 515 across all filing types
Latest filing 2026-02-12 Interim / Quarterly Rep…
Country AU Australia
Listing ASX MPL

About MEDIBANK PRIVATE LIMITED

https://www.medibank.com.au

Medibank Private Limited provides private health insurance and integrated health services. Operating through the Medibank and ahm brands, the organization offers hospital and extras insurance products tailored for individuals, families, and corporate clients. The company extends its core insurance business into health management, providing telehealth services, home-based care, and preventative health initiatives. Its service model emphasizes clinical support and digital health integration to enhance member wellbeing. By managing a broad network of healthcare providers, the organization focuses on delivering coordinated care and health support programs aimed at improving long-term health outcomes for its customer base.

Recent filings

Filing Released Lang Actions
Re-presentation of segment results and terminology changes 4 pages 250.1KB
Interim / Quarterly Report Classification · 95% confidence The document is an announcement dated 15 March 2021 and 13 February 2026, discussing the re-presentation of segment results and changes in terminology for Medibank Health operating segment. It references upcoming half year financial results for 2026 and provides detailed segment financial data for the half year ended 31 December 2024 and the financial year ended 30 June 2025. The document explicitly states that the previously issued financial statements have not been restated and that the re-presented results are to assist investors ahead of the official results announcement. It also references other filings such as Appendix 4D and 4E financial reports for the half year and full year periods, which are available elsewhere. The document is primarily a detailed financial update and segment performance presentation, including re-presented historical data, but it is not the official half year or annual report itself. It is more comprehensive than a simple earnings release as it includes detailed segment data and explanations of changes in presentation and terminology. Given the detailed financial data and segment analysis for a half year period, this fits best as an Interim / Quarterly Report (IR) rather than a brief earnings release or a full annual report. The document length (9804 characters) and content support this classification. Therefore, the filing type is Interim / Quarterly Report (IR) with high confidence. FY 2025
2026-02-12 English
Notification of cessation of securities - MPL 4 pages 14.7KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the lapse of performance rights securities for Medibank Private Limited. It provides specific information about securities that have ceased, including quantities, reasons, and dates. The document is an official announcement related to changes in the company's issued capital, specifically the cessation of certain securities. It does not contain financial statements, management discussion, or detailed financial results. It is not a report but an announcement of a capital change event. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length is under 5,000 characters and is a formal notification of securities cessation, fitting the SHA category rather than a full report or regulatory filing.
2026-01-05 English
Final Director's Notice - Jay Weatherill 3 pages 312.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Final Director’s Interest Notice – Jay Weatherill' and references Appendix 3Z, which is a standard form used in Australian stock exchange (ASX) filings to disclose changes in directors' interests in securities. It details the director's cessation date, securities held, and relevant interests. The document is short (3184 characters) and focuses solely on director shareholding interests and cessation, with no financial data or report content. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades).
2026-01-05 English
Change of Director's Interest - David Koczkar 4 pages 343.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Change of Director’s Interest – David Koczkar' and includes an Appendix 3Y, which is a standard form used in Australian stock exchange filings to disclose changes in directors' interests in securities. The content details the number and nature of securities held by the director before and after the change, the nature of the change (off-market transfer), and confirms no securities were acquired or disposed in some cases. There is no financial performance data, earnings information, or management discussion. The document is a regulatory disclosure about insider shareholdings and changes thereof, fitting the definition of Director's Dealing filings. The document length is 6571 characters, which is consistent with a detailed director dealing notice rather than a brief announcement or a full report. Therefore, the correct classification is Director's Dealing (DIRS).
2025-12-28 English
Notification regarding unquoted securities - MPL 7 pages 21.8KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of unquoted securities under an employee incentive scheme, including performance rights granted to key management personnel. It includes specifics about the number of securities issued, dates, and references to shareholder approvals and ASX listing rules. This type of document is a formal announcement regarding new share issues or capital changes, specifically related to employee incentive securities. It is not a full financial report, earnings release, or management discussion, but rather a capital change notification. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail support a confident classification.
2025-12-18 English
Change of Director's Interest - David Koczkar 4 pages 397.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Change of Director’s Interest – David Koczkar' and references an Appendix 3Y, which is a standard ASX form used to notify changes in directors' interests in securities. The content details the number and class of securities held before and after the change, nature of the change, and confirms compliance with listing rules. There is no financial performance data, earnings information, or management discussion. The document is a regulatory disclosure about insider share transactions by a director, consistent with the definition of Director's Dealing filings. The document length is 6459 characters, which is sufficient to contain the full notice rather than just an announcement of a report. Therefore, the correct classification is Director's Dealing (DIRS).
2025-12-18 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.